| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
2015
|
|
1 |
p. 43
|
artikel
|
| 2 |
Acknowledgements
|
|
|
2015
|
|
1 |
p. 43-43
|
artikel
|
| 3 |
Advances in the treatment of prediabetes
|
Matfin, Glenn
|
|
2010
|
|
1 |
p. 5-14
|
artikel
|
| 4 |
An investigation of the associations among sleep duration and quality, body mass index and insulin resistance in newly diagnosed type 2 diabetes mellitus patients
|
Arora, Teresa
|
|
2016
|
|
1 |
p. 3-11
|
artikel
|
| 5 |
Current best practice in the management of Turner syndrome
|
Shankar, Roopa Kanakatti
|
|
2018
|
|
1 |
p. 33-40
|
artikel
|
| 6 |
Dapagliflozin in patients with type 2 diabetes mellitus
|
Filippatos, Theodosios D.
|
|
2015
|
|
1 |
p. 29-41
|
artikel
|
| 7 |
Dapagliflozin in patients with type 2 diabetes mellitus
|
Filippatos, Theodosios D.
|
|
2015
|
|
1 |
p. 29-41
|
artikel
|
| 8 |
Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® in children requiring growth hormone treatment
|
Pfäffle, Roland
|
|
2013
|
|
1 |
p. 3-11
|
artikel
|
| 9 |
Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
|
Harris, Kira B.
|
|
2015
|
|
1 |
p. 3-18
|
artikel
|
| 10 |
Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
|
Harris, Kira B.
|
|
2015
|
|
1 |
p. 3-18
|
artikel
|
| 11 |
Endocrine and metabolic emergencies: hypocalcaemia
|
Carroll, Richard
|
|
2010
|
|
1 |
p. 29-33
|
artikel
|
| 12 |
Erratum to ‘Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making’
|
|
|
2015
|
|
1 |
p. 42
|
artikel
|
| 13 |
Erratum to ‘Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making’
|
|
|
2015
|
|
1 |
p. 42-42
|
artikel
|
| 14 |
Evidence for statin therapy in polycystic ovary syndrome
|
Sathyapalan, Thozhukat
|
|
2010
|
|
1 |
p. 15-22
|
artikel
|
| 15 |
Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always
|
Raghav, Alok
|
|
2018
|
|
1 |
p. 29-31
|
artikel
|
| 16 |
Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
|
Bayliss, Jacqueline A.
|
|
2013
|
|
1 |
p. 25-36
|
artikel
|
| 17 |
GLP-1 receptor agonists: a review of head-to-head clinical studies
|
Trujillo, Jennifer M.
|
|
2015
|
|
1 |
p. 19-28
|
artikel
|
| 18 |
GLP-1 receptor agonists: a review of head-to-head clinical studies
|
Trujillo, Jennifer M.
|
|
2015
|
|
1 |
p. 19-28
|
artikel
|
| 19 |
Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine
|
Radwan, Mahmoud
|
|
2018
|
|
1 |
p. 3-14
|
artikel
|
| 20 |
Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
|
Malha, Line P.
|
|
2014
|
|
1 |
p. 3-9
|
artikel
|
| 21 |
Hyperglycemia in-hospital management
|
Prieto-Sanchez, Luz Marina
|
|
2011
|
|
1 |
p. 3-7
|
artikel
|
| 22 |
Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits
|
Javed, Zeeshan
|
|
2016
|
|
1 |
p. 12-23
|
artikel
|
| 23 |
Pheochromocytoma – update on disease management
|
Därr, Roland
|
|
2012
|
|
1 |
p. 11-26
|
artikel
|
| 24 |
Review: Clinical approach to the treatment of painful diabetic neuropathy
|
Hovaguimian, Alexandra
|
|
2011
|
|
1 |
p. 27-38
|
artikel
|
| 25 |
Review: Near-normalization of glucose and microvascular diabetes complications: data from ACCORD and ADVANCE
|
O'Connor, Patrick J.
|
|
2011
|
|
1 |
p. 17-26
|
artikel
|
| 26 |
Review: Prevention of type 1 diabetes mellitus using a novel vaccine
|
Orban, Tihamer
|
|
2011
|
|
1 |
p. 9-16
|
artikel
|
| 27 |
Review: Review of therapeutic advances in diabetic retinopathy
|
Chen, Carolyn
|
|
2011
|
|
1 |
p. 39-53
|
artikel
|
| 28 |
Stimulation of incretin secreting cells
|
Pais, Ramona
|
|
2016
|
|
1 |
p. 24-42
|
artikel
|
| 29 |
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
|
Bargiota, Alexandra
|
|
2012
|
|
1 |
p. 27-47
|
artikel
|
| 30 |
The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy
|
Velija-Asimi, Zelija
|
|
2012
|
|
1 |
p. 3-9
|
artikel
|
| 31 |
Therapeutic Advances in Endocrinology and Metabolism: new crossroads in innovation, research, and clinical practice
|
Matfin, Glenn
|
|
2010
|
|
1 |
p. 3-4
|
artikel
|
| 32 |
Therapeutic applications of melatonin
|
Kostoglou-Athanassiou, Ifigenia
|
|
2013
|
|
1 |
p. 13-24
|
artikel
|
| 33 |
Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
|
Jarred, Ghassan
|
|
2010
|
|
1 |
p. 23-28
|
artikel
|
| 34 |
Treating low high-density lipoprotein cholesterol: what is the evidence?
|
Hage, Mirella P.
|
|
2014
|
|
1 |
p. 10-17
|
artikel
|
| 35 |
Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety
|
Mills, Elizabeth P.
|
|
2018
|
|
1 |
p. 15-28
|
artikel
|
Tijdschrift beschrijving